TC Energy: Q4 Earnings Snapshot

TC Energy natural gas pipeline infrastructure spanning North America with flowing energy lines

TC Energy delivered solid fourth-quarter results for 2025, with comparable EBITDA rising 13% year-over-year to $3.0 billion, driven by strong performance across its natural gas pipeline networks amid surging demand from data centers, LNG exports, and power generation. Comparable earnings came in at $0.98 per share, surpassing analyst expectations, while the company announced a 3.2% … Read more

JPMorgan Chase Appoints Veteran Executive as COO to Accelerate AI Integration in Commercial and Investment Banking

Guy Halamish, newly appointed COO of JPMorgan Chase's commercial and investment bank division, leading AI strategy and expansion efforts.

**” JPMorgan Chase has promoted longtime insider Guy Halamish to chief operating officer of its commercial and investment bank division, tasking him with overseeing a major push to expand artificial intelligence tools, appoint dedicated data and analytics leaders across key business lines, and drive efficiency gains through enhanced data governance and AI agent infrastructure. “** … Read more

Prediction: This Will Be the Best AI Stock to Buy in February

Nebius Group logo with futuristic AI cloud infrastructure and GPU clusters in background representing best AI stock opportunity

“Amid recent market volatility and a pullback in several AI names, one stock stands out as the premier opportunity for February: Nebius Group (NBIS). This fast-growing AI infrastructure provider offers compelling upside potential driven by surging demand for cloud-based AI compute resources, an upcoming earnings catalyst, and a valuation that appears discounted relative to its … Read more

The medical devices sector has seen renewed investor interest in early 2026, driven by trends like outpatient procedure expansions, AI integration in healthcare, accelerating M&A activity, and steady demand growth in specialized areas such as respiratory and sleep health technologies. Amid this backdrop, ResMed (RMD), a leader in sleep apnea and respiratory care devices, stands out with its recent performance prompting questions about whether now is the moment to reevaluate its position in portfolios.

Alt Text for featured image : Stock chart and medical sleep apnea device representing ResMed (RMD) investment opportunity in medical devices sector

“ResMed (RMD) delivered strong Q2 fiscal 2026 results with 11% revenue growth to $1.42 billion and adjusted EPS of $2.81, beating expectations amid robust demand for sleep devices and masks. The stock trades around $260, down from its 52-week high near $294, with analysts targeting an average of $299—suggesting 15% upside potential. Key drivers include … Read more

China Metals, Minerals & Steel Companies Database 2026: Up-to-Date Intelligence on Iron & Steel, Aluminium, Non-Ferrous Metals, and Industrial Minerals

Overview of China's major metals and steel production facilities with industrial landscape

China’s metals and minerals sector in 2026 reflects a maturing industry amid shifting domestic demand, capacity controls, and global supply chain pressures. Crude steel output fell sharply in 2025 to 960.81 million metric tons, a 4.4% decline, marking a seven-year low below the 1 billion ton threshold due to weak real estate activity, though exports … Read more

H World Group Launches New Hanting Inn Brand, Advancing Hanting Hotel’s Vision of Hospitality as Everyday Travel Infrastructure

Modern economy hotel room interior with clean design, comfortable bed, and Hanting Inn branding elements

H World Group has unveiled Hanting Inn, a fresh economy hotel sub-brand under its flagship Hanting portfolio. This move strengthens the company’s commitment to making reliable, no-frills lodging a foundational part of routine travel. Targeting price-sensitive guests and asset owners seeking efficient conversions, Hanting Inn leverages the established scale of over 4,500 Hanting hotels and … Read more

Novo Nordisk A/S: Insider Trading Activity by Board Members, Executives, and Associated Persons

Chart showing recent insider buy and sell transactions for Novo Nordisk A/S board members and executives, with values in DKK.

“Novo Nordisk insiders have shown mixed but notable activity in recent months, with a board member purchasing shares signaling confidence amid broader company challenges, while an executive vice president conducted both buys and sells. Overall net activity leans toward modest selling in value terms, occurring against a backdrop of stock volatility driven by guidance adjustments, … Read more

Eli Lilly’s GLP-1 Dominance: Positioning for Multi-Decade Wealth Creation in the Obesity Revolution

Eli Lilly corporate headquarters building with modern architecture and company logo, representing leadership in GLP-1 obesity drugs.

Eli Lilly has seized leadership in the GLP-1 market with tirzepatide-based Mounjaro and Zepbound, driving explosive revenue growth and capturing over 60% U.S. market share. Recent results show combined tirzepatide sales exceeding $36 billion in 2025, with Q4 alone topping $11 billion amid triple-digit gains. The company guides $80-83 billion in 2026 revenue, fueled by … Read more

ConocoPhillips Unveils $1 Billion Cost-Cutting Strategy for 2026

ConocoPhillips oil production facility in the Permian Basin

“ConocoPhillips is set to slash $1 billion from its capital and operating costs in 2026, building on synergies from its Marathon Oil acquisition while maintaining robust production levels and committing to return 45% of cash from operations to shareholders amid fluctuating oil prices.” In a move to bolster efficiency and profitability in a volatile energy … Read more

Will Solana’s Price Recovery Be Challenging? Here’s What On-Chain Signals Suggest

Chart displaying Solana's price trends alongside on-chain activity metrics like TVL and daily transactions

“Solana’s recent price dip to around $135 amid broader market pressures contrasts with robust on-chain activity, including over 3 million daily active addresses and $6.5 billion in TVL, but signals like declining staking yields and persistent sell-offs from major holders suggest hurdles in sustaining a full recovery.” Solana has faced headwinds in early 2026, with … Read more